BioNTech SE - American Depositary Shares (NQ:BNTX)

Three-year Phase 1 Follow-Up Data for mRNA-based Individualized Immunotherapy Candidate Show Persistence of Immune Response and Delayed Tumor Recurrence in Some Patients with Resected Pancreatic Cancer

April 07, 2024

From BioNTech SE

CureVac reveals Phase 2 interim data for its seasonal influenza vaccine in collaboration with GSK. Results show broad antigen coverage with acceptable safety. Positive findings against influenza A...

CureVac, GS Partner Release Data On Influenza Vaccine Study ↗

April 04, 2024

Via Benzinga

Cracking The Code: Understanding Analyst Reviews For BioNTech ↗

March 21, 2024

Via Benzinga

Earnings Outlook For BioNTech ↗

March 19, 2024

Via Benzinga

The 3 Best Bargain Stocks to Buy in Q2 2024 ↗

March 31, 2024

For those who don’t want to chase what everyone else is acquiring, these are intriguing ideas for best bargain stocks to buy.

These biotech stocks to buy are well positioned for growth, and will generate solid returns for investors in the next bull run.

3 Biotech Stocks to Buy for the Next Bull Run: March 2024 ↗

March 26, 2024

BNTX earnings call for the period ending December 31, 2023.

BioNTech Se (BNTX) Q4 2023 Earnings Call Transcript ↗

March 20, 2024

Via The Motley Fool

Topics Earnings

Why Lifecore Biomedical Shares Are Trading Lower By Around 32%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session ↗

March 20, 2024

Shares of Lifecore Biomedical, Inc. (NASDAQ: LFCR) fell sharply during Wednesday’s session after the company announced it concluded its strategic evaluation process, announced management succession and...

Via Benzinga

BioNTech Touts Its Oncology Shift After Reporting Disappointing Fourth Quarter Financials ↗

March 20, 2024

BioNTech SE (NASDAQ: BNTX) is way past its glorious Covid-19 days, when it thrived with Pfizer Inc (NYSE: PFE) for saving the world from the pandemic with their jointly developed vaccine.

Via Benzinga

Stocks Quietly Higher As Central Bank Wraps Up Meeting ↗

March 20, 2024

Stocks are cautiously higher ahead of the conclusion of the central bank's policy meeting.

Via Talk Markets

Topics Economy

BNTX Stock Earnings: BioNTech Misses EPS, Misses Revenue for Q4 2023 ↗

March 20, 2024

BNTX stock results show that BioNTech missed analyst estimates for earnings per share and missed on revenue for the fourth quarter of 2023.

BioNTech also reported plummeting earnings that missed forecasts and issued light 2024 guidance.

BioNTech Tumbles As Fourth-Quarter Sales Dive 65% And Miss Forecasts ↗

March 20, 2024

Via Investor's Business Daily

Why Is BioNTech Stock Trading Lower On Wednesday? ↗

March 20, 2024

BioNTech reported Q4 2023 earnings below expectations, with EPS at €1.90 vs. €9.26 last year. Sales were €1.479 billion, missing consensus. Guidance for 2024 anticipates revenues of €2.5-€3.1 billion,...

Via Benzinga

US Stock Futures Stall As Traders Await Fed Chair Powell's Decision; Analyst Sees S&P 500 Showing 'Signs Of Near-Term Top' ↗

March 20, 2024

Investors remain cautious ahead of the Federal Reserve‘s interest rate decision, with stock futures on Wednesday hinting at a lower opening.

Via Benzinga

Topics Economy Stocks

BioNTech Announces Fourth Quarter and Full Year 2023 Financial Results and Corporate Update

March 20, 2024

From BioNTech SE

BioNTech Announces Appointment of Annemarie Hanekamp to Management Board as Chief Commercial Officer

March 20, 2024

From BioNTech SE

Companies Reporting Before The Bell • UP Fintech Holding (NASDAQ:TIGR) is expected to report quarterly earnings at $0.07 per share on revenue of $207.00 million.

Earnings Scheduled For March 20, 2024 ↗

March 20, 2024

Via Benzinga

Billionaire’s Biotech Bets: 3 Stocks Dominating Bill Gates’ Portfolio ↗

March 13, 2024

One of the primary features of Bill Gates biotech stocks is they are all working towards a cure for HIV and related illnesses.

BNTX DEADLINE ALERT: ROSEN, A GLOBAL AND LEADING LAW FIRM, Encourages BioNTech SE Investors to Secure Counsel Before Important March 12 Deadline in Securities Class Action - BNTX

March 12, 2024

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

BNTX DEADLINE ALERT: ROSEN, A GLOBAL AND LEADING LAW FIRM, Encourages BioNTech SE Investors to Secure Counsel Before Important March 12 Deadline in Securities Class Action - BNTX

Topics Lawsuit

March 12, 2024

WHY: NEW YORK, NY - (NewMediaWire) - March 12, 2024 - Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of BioNTech SE (NASDAQ: BNTX) between March 30, 2022 and...

BNTX DEADLINE TOMORROW: ROSEN, LEADING TRIAL ATTORNEYS, Encourages BioNTech SE Investors to Secure Counsel Before Important March 12 Deadline in Securities Class Action - BNTX

Topics Lawsuit

March 11, 2024

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

BNTX DEADLINE TOMORROW: ROSEN, LEADING TRIAL ATTORNEYS, Encourages BioNTech SE Investors to Secure Counsel Before Important March 12 Deadline in Securities Class Action - BNTX

Topics Lawsuit

March 11, 2024

WHY: NEW YORK, NY - (NewMediaWire) - March 11, 2024 - Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of BioNTech SE (NASDAQ: BNTX) between March 30, 2022 and...

The Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against BioNTech SE (BNTX)

Topics Lawsuit

March 11, 2024

From The Law Offices of Frank R. Cruz

Via Business Wire

BIONTECH SE (NASDAQ: BNTX) DEADLINE ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against BioNTech SE

March 11, 2024

From Bernstein Liebhard LLP

BioNTech to Present Clinical Data Updates for Personalized mRNA-based and Targeted Oncology Candidates at AACR 2024

March 11, 2024

From BioNTech SE

BNTX DEADLINE: ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages BioNTech SE Investors to Secure Counsel Before Important March 12 Deadline in Securities Class Action - BNTX

March 10, 2024

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

BNTX DEADLINE: ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages BioNTech SE Investors to Secure Counsel Before Important March 12 Deadline in Securities Class Action - BNTX

Topics Lawsuit

March 10, 2024

WHY: NEW YORK, NY - (NewMediaWire) - March 10, 2024 - Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of BioNTech SE (NASDAQ: BNTX) between March 30, 2022 and...

BNTX DEADLINE: ROSEN, A LEADING LAW FIRM, Encourages BioNTech SE Investors to Secure Counsel Before Important March 12 Deadline in Securities Class Action - BNTX

Topics Lawsuit

March 09, 2024

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

BNTX DEADLINE: ROSEN, A LEADING LAW FIRM, Encourages BioNTech SE Investors to Secure Counsel Before Important March 12 Deadline in Securities Class Action - BNTX

Topics Lawsuit

March 09, 2024

WHY: NEW YORK, NY - (NewMediaWire) - March 09, 2024 - Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of BioNTech SE (NASDAQ: BNTX) between March 30, 2022 and...